Model-based evaluation of the efficacy and safety of nivolumab once every 4 weeks across multiple tumor types
Zhao, X., Shen, J., Ivaturi, V., Gopalakrishnan, M., Feng, Y., Schmidt, B.J., Statkevich, P., Goodman, V., Gobburu, J., Bello, A., Roy, A., Agrawal, S.Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2019.10.015
Date:
February, 2020
File:
PDF, 2.18 MB
2020